Denes Ban, managing partner at top Israeli venture investor OurCrowd, said the firm had “absolutely” seen cases where Israeli companies were sceptical about the longer-term impact of working with Chinese investors.
Read more here.
Denes Ban, managing partner at top Israeli venture investor OurCrowd, said the firm had “absolutely” seen cases where Israeli companies were sceptical about the longer-term impact of working with Chinese investors.
Read more here.